Ludwig Enterprises, Inc. (LUDG)
| Market Cap | 1.67M -87.6% |
| Revenue (ttm) | n/a |
| Net Income | -1.48M |
| EPS | -0.01 |
| Shares Out | 167.17M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 69,700 |
| Open | 0.0121 |
| Previous Close | 0.0186 |
| Day's Range | 0.0100 - 0.0121 |
| 52-Week Range | 0.0100 - 0.0874 |
| Beta | 1.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
About Ludwig Enterprises
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecula... [Read more]
Financial Performance
Financial StatementsNews
Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer
MIAMI, FL / ACCESS Newswire / May 29, 2025 / Ludwig Enterprises (LUDG) today announced the publication of an abstract on the American Society of Clinical Oncology (ASCO) website in connection with the...
Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab
Ludwig Enterprises, Inc. (OTC:LUDG), previews its first in a pipeline of non-invasive cancer screening tests powered by mRNA biomarker analysis. MIAMI, FL / ACCESS Newswire / May 7, 2025 / Ludwig Ente...
Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology
Marvin S. Hausman MD to discuss screening program at ASCO MIAMI, FLORIDA / ACCESS Newswire / April 29, 2025 / Ludwig Enterprises, Inc. (the "Company") today announced the acceptance for publication in...
Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.
Charles T. Todd, Jr. named CEO and Chair of the Board MIAMI, FLORIDA / ACCESS Newswire / April 23, 2025 / Ludwig Enterprises, Inc. (the "Company"), has appointed Charles T. Todd, Jr. as Chief Executiv...
Ludwig Enterprises Begins PCR Validation Test Process
Final step before the full launch of breast cancer screening program, Revealia™ SPARKS, NV / ACCESSWIRE / November 7, 2024 / Ludwig Enterprises, Inc. (OTC PINK:LUDG), a leading USA-based biotechnology...
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
SPARKS, NV / ACCESSWIRE / October 24, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a leading USA-based biotechnology company, has filed a provisional patent for its breakthrough cancer detection m...
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
This press release replaces the release issued today at 9:15am EDT. Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy.
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. Revealia™: A Breakthrough in Cancer Detection through Advanced AI and Machine L...
Ludwig Announces Acquisition of Intellectual Property and Patent
SPARKS, NV / ACCESSWIRE / September 17, 2024 / Ludwig Enterprises, Inc., (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and pa...
Nova Mentis Assigns Intellectual Property
Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") is pleased to announce it has entered ...
Ludwig Announces Substantial Corporate Initiatives
Revealia™, the world's most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA-based biotechnology company,...
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
SPARKS, NV / ACCESSWIRE / July 9, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA based biotechnology company is pleased to announce that the company has filed a provisional patent titled "mRNA...
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
SPARKS, NV / ACCESSWIRE / March 27, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG): A US-based biotechnology company is pleased to announce that its subsidiary Exousia AI is funding a preclinical stu...
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024
SPARKS, Nev., March 19, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc, (OTC: LUDG): A US-based biotechnology company is pleased to announce it has entered the booming artificial intelligence cancer...
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
SPARKS, Nev., March 06, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc. (OTC: LUDG): A US-based biotechnology company is pleased to announce the successful filing of its provisional patent, title “m...
Ludwig Enterprises mRNA Bladder Cancer Study to be Launched
SPARKS, NV / ACCESSWIRE / January 31, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG): A US-based biotechnology company is pleased to announce that the company has received Continuing Review Approval ...
Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program
SPARKS, NV / ACCESSWIRE / January 9, 2024 / Ludwig Enterprises, Inc, (OTC:LUDG): A US based biotechnology company with a mission to develop cargo delivery platforms containing genetic mRNA and DNA, an...
Ludwig Enterprises Appoints Scott Silverman as CFO
SPARKS, NV / ACCESSWIRE / November 16, 2023 / Ludwig Enterprises, Inc., the Genomics Language Company™, focused on the development of personalized diagnostics and therapeutics targeting illnesses such...
Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company
SPARKS, NV / ACCESSWIRE / November 14, 2023 / Ludwig Enterprises, Inc., (OTC PINK:LUDG), a developer and provider of innovative medical technologies, announced today that the U.S. Securities and Excha...
Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D.
SPARKS, NV / ACCESSWIRE / September 19, 2023 / Ludwig (OTC:LUDG), a provider of innovative medical technologies, announced today Marvin S. Hausman MD has joined Ludwig Enterprises, Inc as Chief Execut...
LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes
Ludwig Enterprises Files Cancer Genomic Patent Machine Learning AI Uncovers Differentially Expressed Genes SPARKS, NV / ACCESSWIRE / May 9, 2023 / Ludwig Enterprises, Inc, (OTC PINK:LUDG) (Ludwig - Th...
Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market
SPARKS, NV / ACCESSWIRE / May 3, 2023 / Ludwig Enterprises, Inc, (OTC PINK:LUDG) (Ludwig - The Genomics Language Company™) is planning to expand its direct to consumer and direct to professional sales...
Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
SPARKS, NV / ACCESSWIRE / April 12, 2023 / Ludwig Enterprises, Inc, (OTC PINK:LUDG) (Ludwig - The Genomics Language Company) is proud to announce that its flagship nutraceutical, NuGenea™ launch will ...
Decoding mRNA for Early Disease Detection, Treatment & Prevention
SPARKS, NV / ACCESSWIRE / March 29, 2023 / Ludwig Enterprises, Inc. (OTC PINK:LUDG): Personalized genetic sequencing has taken a front seat in current healthcare attempts to optimize diagnosis and tre...
Ludwig Enterprises Announces Agreement with Summit Bancorp to Assist with Cross Listing on the Canadian Stock Exchange
SPARKS, NV / ACCESSWIRE / March 23, 2023 / Ludwig Enterprises, Inc. (OTC PINK:LUDG) (Ludwig - The Genomics Language Company ™) is pleased to announce that it has signed an agreement with Summit Bancor...